Twist Bioscience Corp Accounts Receivable, after Allowance for Credit Loss, Current
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2026-08-03
- 2026-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $65.06M.
- 2026-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $64.15M.
- 2025-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $50.06M.
- 2025-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $57.02M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2026-06-30 | $65.06M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $64.15M 10-Q · filed 2026-05-04 |
| 2025-12-31 | $50.06M 10-Q/A · filed 2026-02-26 |
| 2025-09-30 | $57.02M 10-Q · filed 2026-08-03 |
| 2025-06-30 | $49.85M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $49.95M 10-Q · filed 2025-05-05 |
| 2024-12-31 | $39.31M 10-Q · filed 2025-02-03 |
| 2024-09-30 | $34.90M 10-K · filed 2025-11-17 |
| 2024-06-30 | $31.99M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $35.99M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $35.35M 10-Q · filed 2024-02-02 |
| 2023-09-30 | $44.06M 10-K · filed 2024-11-18 |
| 2023-06-30 | $42.58M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $48.19M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $44.44M 10-Q · filed 2023-02-07 |
| 2022-09-30 | $40.29M 10-K · filed 2023-11-21 |
| 2022-06-30 | $41.20M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $34.88M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $32.87M 10-Q · filed 2022-02-09 |
| 2021-09-30 | $28.55M 10-K/A · filed 2023-06-05 |
| 2021-06-30 | $28.12M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $27.29M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $25.49M 10-Q · filed 2021-02-09 |
| 2020-09-30 | $26.38M 10-K · filed 2021-11-23 |
| 2020-06-30 | $13.35M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $14.83M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $13.05M 10-Q · filed 2020-02-10 |
| 2019-09-30 | $12.10M 10-K · filed 2020-11-27 |
| 2019-06-30 | $11.70M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $8.00M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $6.98M 10-Q · filed 2019-02-11 |
| 2018-09-30 | $5.42M 10-K · filed 2019-12-13 |